中国北京建国门外大街 1 号国贸写字楼 2 座 12-14 层 100004 12-14th Floor, China World Office 2, No. 1 Jianguomenwai Avenue, Beijing 100004, China 电话 Tel: +86 10 6563 7181 传真 Fax: +86 10 6569 3838 电邮 Email: beijing@tongshang.com 网址 Web: www.tongshang.com 北京市通商律师事务所 关于新华人寿保险股份有限公司 2023 年第二次临时股东大会之法律意见书 致：新华人寿保险股份有限公司 根据《中华人民共和国公司法》(以下简称"《公司法》")、《中华人民共和 国证券法》(以下简称"《证券法》")、《上市公司股东大会规则》(以下简称"股 东大会规则")等相关法律、法规以及《新华人寿保险股份有限公司章程》(以下 简称"公司章程")、《新华人寿保险股份有限公司股东大会议事规则》(以下简称 "股东大会议事规则")的规定，北京市通商律师事务所(以下简称"通商")接受新 华人寿保险股份有限公司(以下简称"公司")的委托，指 ...

NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 董事名單與其角色和職能 新華人壽保險股份有限公司董事會（「董事會」）成員載列如下： 執行董事 張 泓 董事會下設五個專業委員會，各專業委員會的組成如下： | | | 委員會 | | | 審計與關聯 交易控制 | 提名薪酬 | 風險管理與 消費者權益 | | --- | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | 戰略委員會 | 投資委員會 | 委員會 | 委員會 | 保護委員會 | | 張 | 泓 | | M | M | | | | | 楊 | 毅 | | M | C | M | | | | 何興達 | | | | M | | | M | | 楊 | 雪 | | | | | M | M | | 胡愛民 | | | M | M | | | | | 李琦強 | | | | | M | M | M | | 馬耀添 | | | | | | M | M | | 賴觀榮 | | | M | M | M | | | | 徐 | 徐 | | | | M | C | M | | ...

新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 新华人寿保险股份有限公司（以下简称"本公司"）董事会于 2023 年 9 月 18 日收到独立董事耿建新先生的辞职函，因任独立董事时间已满六年，根据相 关监管规定，耿建新先生向董事会提出辞去本公司独立董事、董事会审计与关联 交易控制委员会主任委员及提名薪酬委员会委员职务。 | A股股票代码：601336 | A股股票简称：新华保险 编号：2023-043号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 关于独立董事辞职的公告 根据中国证券监督管理委员会《上市公司独立董事管理办法》以及《新华人 寿保险股份有限公司章程》等相关规定，耿建新先生的辞职不会导致公司董事会 人数低于法定人数，不会导致独立董事人数少于董事会成员的三分之一或者董事 会专业委员会中独立董事所占比例不符合法律规定。 耿建新先生的辞职函自送达本公司董事会之日起生效，其辞职不影响本公司 董事会的正常运作。耿建新先生确认其与本 ...

上述原保险保费收入数据未经审计，提请投资者注意。 | A股股票代码：601336 | A股股票简称：新华保险 编号：2023-042号 | | --- | --- | | H股股票代码： 01336 | H股股票简称：新华保险 | 新华人寿保险股份有限公司 保费收入公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确 性和完整性承担法律责任。 根据中华人民共和国财政部《企业会计准则第 25 号——原保险合同》（财 会〔2006〕3 号）及《保险合同相关会计处理规定》（财会〔2009〕15 号），新华 人寿保险股份有限公司于 2023 年 1 月 1 日至 2023 年 8 月 31 日期间累计原保险 保费收入为人民币 12,786,123 万元。 特此公告。 新华人寿保险股份有限公司董事会 2023 年 9 月 11 日 ...

新華人壽保險股份有限公司 NEW CHINA LIFE INSURANCE CO., LTD. (於中華人民共和國註冊成立的股份有限公司) 股份代號: 01336 2023 中期報告 New China Insurance Tower, A12 Jianguomenwai Avenue, Chaoyang District, Beijing 100022,P.R.C www.newchinalife.com 新華人壽保險股份有限公司 北京市朝陽區建國門外大街甲12號新華保險大廈 NEW CHINA LIFE INSURANCE CO., LTD. 全國統一客服電話 新華保險服務號 投資者關係網站 New China Life Insurance Company Ltd. 新華人壽保險股份有限公 司 中期報告 2023 重要 提示 新華人壽保險股份有限公司 1 1. 本公司董事會、監事會及董事、監事、高級管理人員保證中期報告內容的真實、準確、完整，不存在虛假記 載、誤導性陳述或重大遺漏，並承擔個別和連帶的法律責任。 2. 本公司第八屆董事會第九次會議於2023年8月29日審議通過了《2023年中期報告》。會議應 ...

致：香港交易及結算所有限公司 公司名稱: 新華人壽保險股份有限公司 呈交日期: 2023年9月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 | 01336 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,034,107,260 | RMB | | 1 RMB | | 1,034,107,260 | | 增加 / 減少 (-) | | | | | | RMB | | | | 本月底結存 | | | 1,034,107,260 | RMB | | 1 RMB | | 1,034,107,260 | | 2. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | ...

二〇二三年九月五日 北京 新华人寿保险股份有限公司 2023 年第二次临时股东大会 会议材料 会议地点 ：北京市朝阳区建国门外大街甲 12 号新华保险大厦 21 层 会议召集人：新华人寿保险股份有限公司董事会 议程内容 普通决议事项 关于选举杨玉成先生为第八届董事会执行董事的议案 2/4 一、宣布会议开始及会议议程 二、审议议案 1/4 新华人寿保险股份有限公司 2023 年第二次临时股东大会议程 会议时间 ：2023 年 9 月 25 日（星期一）下午 14 点 30 分 公司于 2023 年 8 月 29 日召开的第八届董事会第九次会议审议通过了《关 于提名杨玉成先生为第八届董事会执行董事候选人的议案》，同意提名杨玉成先 生为公司第八届董事会执行董事候选人。杨玉成先生简历请见附件。 现将上述议案提请股东大会审议。 附件：杨玉成先生简历 新华人寿保险股份有限公司董事会 3/4 三、回答股东提问 四、宣布出席会议股东及股东代理人人数、代表股份数 五、现场投票表决 六、休会、统计现场表决结果 七、宣布现场表决结果 议案 关于选举杨玉成先生为第八届董事会执行董事的议案 各位股东： 根据相关法律法规及《新华人寿保险 ...

新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存在任 何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整 性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2023 年第二次临时股东大会（以下简称"本次股东大会"或"股东大会"） 召开的日期时间：2023 年 9 月 25 日 14 点 30 分 召开地点：北京市朝阳区建国门外大街甲 12 号新华保险大厦 21 层 A 股证券代码：601336 A 股证券简称：新华保险 公告编号：2023-041 H 股证券代码： 01336 H 股证券简称：新华保险 新华人寿保险股份有限公司 关于召开 2023 年第二次临时股东大会的通知 股东大会召开日期：2023年9月25日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：新华人寿保险股份有限公司（以下简称"本公司"或"公司"） 董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合 的方式 (四) 现场会议召开的日期、时间和地点 (五) 网络投票的系统、起止日期和投票时间。 网络投票 ...

Financial Performance - Total assets reached 1,309,179 million yuan[9] - Net profit attributable to parent company shareholders was 9,978 million yuan[9] - Shareholders' equity attributable to parent company shareholders stood at 112,286 million yuan[9] - Operating income was 48,943 million yuan[9] - Annualized total investment yield was 3.7%[9] - New business value for the first half of the year was 2,474 million yuan[9] - Comprehensive solvency adequacy ratio was 239.02%[9] - Embedded value reached 266,479 million yuan[9] - Original insurance premium income reached 107.851 billion yuan, a year-on-year increase of 5.1%[11] - New business value increased to 2.474 billion yuan, a year-on-year growth of 17.1%[11] - Investment scale reached 1,259.159 billion yuan, an increase of 8.8% compared to the end of the previous year[12] - Annualized total investment yield was 3.7%, and annualized net investment yield was 3.4%[12] - Third-party asset management scale reached 624 billion yuan, a year-on-year increase of 45.0%[12] - Total assets increased to 13,091.79 billion yuan, a year-on-year growth of 7.8%[20] - Net profit attributable to parent company shareholders was 99.78 billion yuan, a year-on-year increase of 8.6%[20] - Operating cash flow reached 655.08 billion yuan, a year-on-year increase of 15.3%[20] - Investment assets increased by 8.8% to 1,259,159 million yuan as of June 30, 2023, compared to 1,157,622 million yuan in the same period last year[25] - Annualized total investment yield decreased by 0.5 percentage points to 3.79% in the first half of 2023, down from 4.2% in the same period last year[25] - Insurance service income decreased by 6.5% to 26,593 million yuan in the first half of 2023, compared to 28,440 million yuan in the same period last year[25] - Long-term first-year premiums increased by 14.8% to 33,859 million yuan in the first half of 2023, with first-year regular premiums surging 42.9% to 17,482 million yuan[29] - Original insurance premium income grew by 5.1% to 1,078.51 billion yuan in the first half of 2023, with long-term first-year premiums accounting for 338.59 billion yuan[31] - Embedded value reached 2,664.79 billion yuan as of June 30, 2023, an increase of 4.3% compared to the end of the previous year[32] - New business value increased by 17.1% to 2.474 billion yuan in the first half of 2023[32] - Bancassurance channel's long-term first-year premiums grew by 17.7% to 25,440 million yuan in the first half of 2023, with first-year regular premiums doubling to 9,511 million yuan[35] - Individual insurance channel's monthly average qualified rate improved by 1.1 percentage points to 18.6% in the first half of 2023, with monthly average comprehensive productivity per capita surging 111.0% to 8,103 yuan[36] - Bancassurance channel achieved premium income of 36.83 billion yuan, a year-on-year increase of 18.1%, with long-term first-year premium reaching 9.511 billion yuan, up 100.0%[37] - Group insurance channel premium income was 1.81 billion yuan, down 1.6%, while policy-based health insurance premium income grew 13.6% to 610 million yuan, covering 17.496 million customers[38] - Total original insurance premium income reached 1,078.51 billion yuan, up 5.1%, with traditional insurance premium income surging 81.3% to 612.50 billion yuan[41] - Shandong, Beijing, and Henan branches contributed 56.8% of the company's premium income, with Shandong branch generating 10.223 billion yuan, up 2.4%[42][43] - 13-month persistency ratio improved to 89.2%, up 4.9 percentage points, while 25-month persistency ratio declined to 79.0%, down 3.7 percentage points[43] - Insurance contract liabilities increased by 9.0% to 1,103.982 billion yuan, with unearned premium liabilities rising 9.0% to 1,090.553 billion yuan[44][46] - Insurance service income decreased by 6.5% to 26.593 billion yuan, while insurance service expenses increased by 1.0% to 17.590 billion yuan[45] - Total investment assets reached 1,259.159 billion yuan, up 8.8%, with third-party asset management scale growing 45% to 624 billion yuan[47] - Total investment assets increased by 8.8% to 1,259,159 million as of June 30, 2023, compared to 1,157,622 million at the end of 2022[48] - Bond investments grew by 19.9% to 577,849 million, accounting for 45.9% of total investment assets[48] - Stock investments increased by 20.1% to 98,681 million, representing 7.8% of total investment assets[48] - Non-standard asset investments decreased by 374.10 billion to 1,837.03 billion, accounting for 14.6% of total investment assets, down 4.5 percentage points from the end of 2022[52] - Net investment income decreased by 15.9% to 20,047 million, with a yearized net investment yield of 3.4%, down 1.2 percentage points[50] - Total investment income increased slightly by 1.5% to 21,899 million, with a yearized total investment yield of 3.7%, down 0.5 percentage points[50] - Core solvency adequacy ratio improved to 146.91% as of June 30, 2023, up from 140.53% at the end of 2022[56] - Comprehensive solvency adequacy ratio increased to 239.02% as of June 30, 2023, compared to 238.20% at the end of 2022[56] - Operating cash flow increased by 15.3% to 65,508 million, driven by higher cash receipts from insurance premiums[57] - Investing cash outflow increased by 58.3% to 76,696 million, mainly due to higher cash payments for investments[58] - Cash and cash equivalents amounted to RMB 18.586 billion, with fixed deposits totaling RMB 244.559 billion as of the reporting period[59] - The company's investment portfolio, including bonds, debts, stocks, and funds, reached RMB 981.348 billion, providing liquidity for unexpected cash needs[59] - Total ceded premiums for reinsurance business were RMB 1.357 billion, with Swiss Re Beijing Branch accounting for RMB 926 million and China Life Reinsurance Co., Ltd. for RMB 354 million[63] - Premiums ceded by insurance type: life insurance RMB 129 million, health insurance RMB 1.215 billion, and accident insurance RMB 13 million[64] - The company's asset management subsidiary reported total assets of RMB 4.207 billion, net assets of RMB 3.559 billion, and a net profit of RMB 315 million[64] - Xinhua Pension's total assets stood at RMB 6.075 billion, with net assets of RMB 5.327 billion and a net profit of RMB 15 million[64] - The company's Hong Kong asset management subsidiary reported total assets of HKD 508 million, net assets of HKD 441 million, and a net profit of HKD 5 million[64] - The company's Hefei support center reported total assets of RMB 2.376 billion, net assets of RMB 2.334 billion, and a net loss of RMB 45 million[64] - The company's Hainan pension business reported total assets of RMB 1.067 billion, net assets of RMB 1.062 billion, and a net loss of RMB 15 million[64] - The company's health technology subsidiary reported total assets of RMB 1.797 billion, net assets of RMB 1.780 billion, and a net profit of RMB 3 million[64] - Total assets increased to RMB 1,309,179 million as of June 30, 2023, compared to RMB 1,214,936 million at the end of 2022[136] - Total liabilities rose to RMB 1,196,870 million as of June 30, 2023, up from RMB 1,116,940 million at the end of 2022[138] - Shareholders' equity attributable to the parent company increased to RMB 112,286 million as of June 30, 2023, compared to RMB 97,975 million at the end of 2022[141] - Insurance contract liabilities grew to RMB 1,103,982 million as of June 30, 2023, up from RMB 1,013,191 million at the end of 2022[138] - Financial investments, including trading financial assets, debt investments, and other debt investments, totaled RMB 975,562 million as of June 30, 2023[137] - Undistributed profits increased to RMB 94,987 million as of June 30, 2023, compared to RMB 76,910 million at the end of 2022[141] - Monetary funds stood at RMB 18,599 million as of June 30, 2023, up from RMB 17,603 million at the end of 2022[137] - Fixed-term deposits increased to RMB 244,559 million as of June 30, 2023, compared to RMB 227,547 million at the end of 2022[137] - Other receivables decreased to RMB 2,469 million as of June 30, 2023, down from RMB 5,461 million at the end of 2022[137] - Deferred tax assets decreased to RMB 4,711 million as of June 30, 2023, compared to RMB 7,890 million at the end of 2022[137] - Revenue for the first half of 2023 was RMB 48,943 million, a decrease of 4.7% compared to RMB 51,378 million in the same period of 2022[142] - Insurance service income for the first half of 2023 was RMB 26,593 million, a decrease of 6.5% compared to RMB 28,440 million in the same period of 2022[142] - Net profit attributable to shareholders of the parent company for the first half of 2023 was RMB 9,978 million, an increase of 8.6% compared to RMB 9,190 million in the same period of 2022[144] - Basic earnings per share for the first half of 2023 were RMB 3.20, an increase of 8.5% compared to RMB 2.95 in the same period of 2022[144] - Total comprehensive income for the first half of 2023 was RMB 1,338 million, a decrease of 69.5% compared to RMB 4,392 million in the same period of 2022[144] - Total equity attributable to shareholders of the parent company as of June 30, 2023 was RMB 112,286 million, an increase of 4.3% compared to RMB 107,591 million as of December 31, 2022[146] - The impact of the new insurance contract standards on equity as of June 30, 2023 was a decrease of RMB 4,909 million[146] - The impact of the new financial instrument standards on equity as of June 30, 2023 was an increase of RMB 16,351 million[146] - Total assets as of June 30, 2023 were RMB 1,142,860 million, an increase of 5.2% compared to RMB 1,086,090 million as of December 31, 2022[146] - Total liabilities as of June 30, 2023 were RMB 1,030,574 million, an increase of 5.4% compared to RMB 978,499 million as of December 31, 2022[146] - Total comprehensive income for the first half of 2023 was RMB 729 million, compared to RMB 5,217 million in the same period of 2022[150] - Net cash flow from operating activities increased to RMB 6,550.8 million in H1 2023, up from RMB 5,679.6 million in H1 2022[153] - Investment cash outflows significantly increased to RMB 404,624 million in H1 2023 from RMB 279,566 million in H1 2022[152] - Cash received from insurance premiums rose to RMB 112,872 million in H1 2023, compared to RMB 102,375 million in H1 2022[153] - Net cash flow from financing activities improved to RMB 12,140 million in H1 2023 from negative RMB 6,216 million in H1 2022[154] - Total equity decreased to RMB 109,706 million as of June 30, 2023, from RMB 112,353 million at the beginning of the year[150] - Cash and cash equivalents balance increased to RMB 18,586 million at the end of H1 2023, up from RMB 17,586 million at the beginning of the period[155] - Claims paid for insurance contracts increased to RMB 36,860 million in H1 2023 from RMB 32,977 million in H1 2022[152] - Investment income and interest received grew to RMB 21,570 million in H1 2023 from RMB 18,655 million in H1 2022[153] - Cash paid for employee benefits decreased to RMB 4,379 million in H1 2023 from RMB 4,688 million in H1 2022[152] - The company's total assets increased by RMB 16,345 million due to the adoption of the new financial instruments standards, from RMB 1,214,936 million to RMB 1,231,281 million as of January 1, 2023[162] - The new financial instruments standards resulted in a reclassification of financial assets, with RMB 333,546 million classified as trading financial assets and RMB 252,023 million as debt investments[164] - The company's shareholder equity increased by RMB 16,351 million to RMB 114,347 million as of January 1, 2023, due to the impact of the new financial instruments standards[165] - The company's financial liabilities were reclassified, with RMB 25,874 million classified as trading financial liabilities as of January 1, 2023[167] - The company's deferred tax assets decreased by RMB 5,445 million to RMB 2,445 million due to the adoption of the new financial instruments standards[164] - The company's other assets increased by RMB 930 million to RMB 2,652 million as of January 1, 2023, due to the impact of the new financial instruments standards[164] - The company's other payables increased by RMB 73 million to RMB 13,913 million as of January 1, 2023, due to the impact of the new financial instruments standards[167] - The company's bonds payable increased by RMB 211 million to RMB 10,211 million as of January 1, 2023, due to the impact of the new financial instruments standards[167] - The company's other liabilities decreased by RMB 280 million to RMB 2,144 million as of January 1, 2023, due to the impact of the new financial instruments standards[167] - The total impairment provision under the old financial instrument criteria was RMB 7,570 million, with a reclassification of RMB 5,970 million and a re-measurement of expected loss provision of RMB 220 million, resulting in a credit loss provision of RMB 1,820 million under the new financial instrument criteria[171] - The impairment provision for available-for-sale financial assets was RMB 7,570 million, which was fully reclassified under the new financial instrument criteria[173] - The impairment provision for debt investments under the new financial instrument criteria was RMB 167 million, with RMB 76 million reclassified and RMB 91 million newly measured[173] - The impairment provision for other debt investments under the new financial instrument criteria was RMB 1,574 million, with RMB 1,524 million reclassified and RMB 50 million newly measured[173] - The company adopted the new insurance contract criteria starting from January 1, 2023, which includes comprehensive provisions for recognition, measurement, presentation, and disclosure of insurance contracts[174] - For insurance contracts with direct participation features, the company uses the variable fee approach for measurement, while for contracts with a term of one year or less, the premium allocation approach is used[174] - The company applies the general model for other insurance contracts and uses the general model or premium allocation approach for reinsurance contracts[174] - The company adjusted the cumulative impact of the new insurance contract criteria on retained earnings or other comprehensive income as of January 1, 2022, and restated prior period comparable data[177] - The new financial instrument criteria require financial assets and liabilities to be initially measured at fair value, with transaction costs either expensed or capitalized depending on the classification[180] - The effective interest rate method is used to calculate the amortized cost of financial assets or liabilities and to allocate interest income or expense over the relevant periods[180] - Financial assets are classified and measured at amortized cost, fair value through other comprehensive income, or fair value through profit and loss based on their contractual cash flows and business model[182] - Financial assets measured at amortized cost include monetary funds, reverse repurchase agreements, debt investments, time deposits, and other receivables[182] - Financial assets measured at fair value through other comprehensive income are classified as other debt investments and include those managed for both collecting contractual cash flows and selling[182] - Financial assets measured at fair value through profit and loss include those not meeting the criteria for amortized cost or fair value through other comprehensive income[184] - Interest income for financial assets measured at amortized cost is recognized using the effective interest method, with adjustments for credit-impaired assets[184] - Financial assets measured at fair value through other comprehensive income have their fair value changes recognized in other comprehensive

新华人寿保险股份有限公司（以下简称"公司"）于 2023 年 8 月 15 日以电 子邮件方式向全体董事发出第八届董事会第九次会议（以下简称"会议"）通知 和材料，会议于 2023 年 8 月 29 日在北京市以现场会议方式召开。会议应到董事 11 人，现场出席董事 11 人，公司监事和部分高级管理人员列席了会议。会议的 召集、召开符合《中华人民共和国公司法》《新华人寿保险股份有限公司章程》 和《新华人寿保险股份有限公司董事会议事规则》的有关规定，所作的决议合法、 有效。 全体董事一致推举董事杨毅主持本次会议，经与会董事审议和现场表决，形 成如下会议决议： 新华人寿保险股份有限公司 第八届董事会第九次会议决议公告 新华人寿保险股份有限公司董事会及全体董事保证本公告内容不存 在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的真实性、准 确性和完整性承担法律责任。 一、审议通过了《关于 2023 年中期报告（A 股/H 股）的议案》。 表决情况：同意 11 票，反对 0 票，弃权 0 票。 二、审议通过了《关于制定〈资本管理办法（暂行）〉的议案》。 表决情况：同意 11 票，反对 0 票，弃权 0 票。 A股股 ...